Resources from the same session
3982 - Effects of Abiraterone Acetate plus Prednisone/Prednisolone in High and Low Risk Metastatic Hormone Sensitive Prostate Cancer
Presenter: Alex Hoyle
Session: Presidential Symposium 2
Resources:
Abstract
Slides
Webcast
1922 - Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE (NCT00268476)
Presenter: Chris Parker
Session: Presidential Symposium 2
Resources:
Abstract
Slides
Webcast
3281 - JAVELIN Renal 101: a randomized, phase 3 study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)
Presenter: Robert Motzer
Session: Presidential Symposium 2
Resources:
Abstract
Slides
Webcast
4000 - Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial
Presenter: Kathleen Moore
Session: Presidential Symposium 2
Resources:
Abstract
Slides
Webcast
Presidential Symposium 2 - Invited discussant
Presenter: Jonathan Ledermann
Session: Presidential Symposium 2
Resources:
Slides
Webcast
Presidential Symposium 2 - Invited discussant
Presenter: Robert Bristow
Session: Presidential Symposium 2
Resources:
Slides
Webcast
Presidential Symposium 2 - Invited discussant
Presenter: Viktor Grünwald
Session: Presidential Symposium 2
Resources:
Slides
Webcast